Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
38.10B | 36.98B | 34.87B | 29.61B | 26.93B | 25.17B | Gross Profit |
20.12B | 19.50B | 17.90B | 13.11B | 12.98B | 13.20B | EBIT |
5.84B | 4.88B | 3.88B | -698.00M | 383.00M | -2.05B | EBITDA |
7.76B | 6.69B | 5.72B | 1.62B | 2.59B | 274.00M | Net Income Common Stockholders |
3.96B | 3.64B | 5.30B | -1.78B | 122.00M | -4.72B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
20.68B | 20.13B | 20.40B | 19.48B | 18.79B | 21.82B | Total Assets |
59.10B | 51.34B | 51.16B | 45.40B | 50.80B | 46.66B | Total Debt |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Net Debt |
-20.68B | -20.13B | -20.40B | -19.28B | -18.69B | -21.22B | Total Liabilities |
9.03B | 8.40B | 11.37B | 8.78B | 9.96B | 6.65B | Stockholders Equity |
50.07B | 42.94B | 39.79B | 36.62B | 40.83B | 40.01B |
Cash Flow | Free Cash Flow | ||||
0.00 | 1.54B | 4.40B | 982.00M | -2.05B | -415.00M | Operating Cash Flow |
0.00 | 3.73B | 5.51B | 3.07B | -52.00M | 1.85B | Investing Cash Flow |
0.00 | -2.47B | -911.00M | -1.36B | -1.36B | -1.72B | Financing Cash Flow |
0.00 | -1.13B | -3.47B | -1.12B | -1.12B | -1.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥50.83B | 6.02 | 6.49% | 29.41% | 10.66% | ||
77 Outperform | ¥29.73B | 7.11 | 3.99% | 38.95% | 66.23% | ||
74 Outperform | ¥7.33B | 9.51 | 3.68% | -7.57% | -55.26% | ||
74 Outperform | $470.31B | 9.25 | 18.38% | 4.74% | -8.81% | 14.09% | |
68 Neutral | ¥22.80B | 5.76 | 5.17% | 0.55% | -24.89% | ||
61 Neutral | $6.68B | 11.75 | 3.01% | 3.94% | 2.61% | -21.96% | |
47 Neutral | $82.21B | ― | -4.07% | 2.66% | -29.42% | -154.74% |